Robotic surgery shows comparable or superior results to traditional laparoscopic procedures for treating kidney disease, benefiting more patients due to reduced learning curve. More surgeons may master the technique, expanding access to minimally invasive treatment.
Researchers found that dutasteride is impractical due to high costs and marginal impact on survival and quality of life for at-risk groups. The medication's annual cost of $1,400 outweighs its benefits, making it less effective as a preventive measure.
Patients with large kidney tumors benefit from nephron-sparing surgery, which preserves more kidney tissue and reduces chronic kidney disease risk. Researchers found that this approach resulted in better long-term kidney health outcomes compared to radical nephrectomy.
A Swedish study found that PSA screening nearly halves prostate cancer mortality after 14 years. However, the screening was associated with a risk of impotence and urinary incontinence, albeit at lower rates than expected.
Women undergoing gastric band surgery reported significant improvements in urinary function and quality of life, while men experienced worsening erectile function. The study highlights the need for further research into the effects of weight loss surgery on urinary and sexual function.
Researchers found that a slight rise in PSA levels among men taking dutasteride was a stronger indicator of prostate cancer than rising PSA levels in men on a placebo. The study suggests that the drug enhances the ability to detect high-grade cancers, making the PSA test more effective for early diagnosis and treatment.
A study by the University of Michigan Health System found that specialists spend over 650,000 work weeks on routine follow-up care for patients with common chronic conditions. Delegating a proportion of this care could create system-wide efficiencies and free up specialists to focus on new patients and complex cases.
Researchers found that the protein N-cadherin is upregulated in prostate cancer that does not respond to hormone therapy, making it a potential target for therapy. The study suggests that a monoclonal antibody targeting N-cadherin may be effective in treating this aggressive form of prostate cancer.
Demetrius H. Bagley, M.D., a renowned urologist and researcher at Thomas Jefferson University, has received the Karl Storz Lifetime Achievement Award in Endourology for his pioneering work in ureteroscopic management of upper tract pathology.
A new study published in the Journal of the American College of Surgeons found that airbags significantly reduce the risk of kidney injury in car crashes. The research analyzed over 2,800 records and found a 45-52% reduction in renal injuries with airbag deployment.
Researchers have found that a cholesterol-lowering drug can reduce enlarged prostates in hamsters to the same extent as a commonly used BPH treatment, working even better when combined. The study suggests lowering cholesterol may reduce BPH in men, potentially preventing its development through exercise and diet.
A recent study published in European Urology found that nearly 87% of prostate cancer patients who underwent robot-assisted radical prostatectomy had no recurrence after five years. The study, led by Dr. Mani Menon, suggests that robotic-assisted surgery is an effective treatment for localized prostate cancer.
A nationwide survey of over 5,800 individuals ages 14 to 94 found diverse patterns of sexual acts, condom use, and same-sex encounters. Condoms were used by one in four men and one in three women, with increased usage among some groups.
Researchers identified 79 microRNAs linked to bladder cancer, showing promise for early detection through existing laboratory tests. The new method measures microRNA presence or absence in bodily fluids with high accuracy, comparable to current gold standard testing.
Researchers at St. Michael's Hospital discovered that the cholesterol-lowering drug Crestor suppressed human prostate cancer cells grown in mice. This pre-clinical evidence suggests statins could be an effective treatment for prostate cancer, potentially offering a safer alternative to existing therapies.
The Endocrine Society recommends that every newborn be screened for CAH, and positive results be followed up with confirmatory tests. The guideline also outlines treatment recommendations, including minimizing glucocorticoid dosage and considering patients' quality of life.
Brothers of men with prostate cancer are at a higher risk of diagnosis due to increased diagnostic activities, not genetic mutations. Incidence is highest among men with two brothers diagnosed, and detection bias contributes significantly.
The NYU Urothelial Biology Team has received a five-year, $8.2 million grant from the NIDDK to investigate bladder biology and diseases such as UTI. The team aims to understand how disease-causing bacteria interact with host urothelial cells, which is crucial for developing novel treatments for recurrent UTI and other urologic diseases.
A new case series in European Urology introduces a purely intrafascial approach for robot-assisted laparoscopic prostatectomy, aiming to avoid damage to critical structures. The study reports promising results with no perioperative major complications, but highlights the need for well-designed studies to evaluate its advantages.
A pilot study published in the Journal of Endourology suggests that CO2 laser technology used with robotic prostate cancer surgery may preserve sensitive nerve areas necessary for erections and urinary continence. The technology, known as BeamPath, was found to be easy to manipulate and accurate.
A new study led by researchers at UCSF found that surgery is more effective than radiation and hormone therapies for men with high-risk prostate cancer. The study analyzed data from 7,538 men with localized disease and found a significant difference in survival rates between surgical removal of the prostate and other treatment options.
A new technique preserves periprostatic anatomy by keeping intact the pubovesical complex, achieving a higher rate of urinary continence after radical prostatectomy. The study reports a 25.7% weighted mean continence rate immediately after catheter removal.
A study of 587 women aged 18-95 found that 63% experienced female sexual dysfunction (FSD), with orgasm issues affecting the most people. FSD increased with age, except for orgasm problems, which rose in older age groups.
A high-fat diet is found to activate nuclear factor kappa B (NF-κB) in the prostate, leading to inflammation, oxidative stress, and proliferation. The study provides direct evidence of a link between a high-fat diet and an increased risk of benign prostatic hyperplasia, prostatitis, and prostate cancer.
Researchers found that statin use reduced prostate cancer recurrence by 30 percent, with higher doses associated with a greater risk reduction. Men taking higher doses of statins had a 43-50% lower risk of recurrence compared to those taking lower doses.
A comprehensive genomic analysis of prostate cancer has identified key alterations in the androgen receptor pathway and defined subsets of low- and high-risk disease. The study provides valuable resources for cancer research and may lead to the creation of a genetic-based test to determine which tumors require aggressive treatment.
A pre-emptive multimodal pain regimen reduced opioid analgesic use in robotic prostatectomy patients. The study found a mean opioid dose of 49.1 mg for those receiving the regimen, compared to 75.3 mg for standard care.
European Urology has released a new impact factor of 7,667, highlighting its status as a top urological forum for over 35 years. The journal is read by 20,000 urologists globally and offers high-quality papers, fast response, and an international profile.
Researchers found significant association between chlordecone exposure and prostate cancer risk, with higher risk seen in individuals with family history or exposure to Western lifestyle. Genetic susceptibility factors may play a role in this relationship.
A Mayo Clinic study found that interrupting blood flow for more than 20 minutes during kidney cancer surgery increases the risk of chronic kidney disease. Limiting ischemia time can help avoid this complication.
Researchers at Henry Ford Hospital found that adenocarcinoma of the bladder has a poor overall survival rate, but certain factors can improve prognosis. Patients diagnosed at age 60 or younger and those with well-differentiated, localized tumors may have better chances of survival.
Researchers at UT Southwestern Medical Center compared the outcomes of two surgical procedures designed to alleviate symptoms of stress urinary incontinence. Both procedures, transvaginal sling and transobturator midurethral sling, appear to be similarly effective in women up to 12 months after the procedures were performed.
A six-year study by researchers at Henry Ford Hospital found that heavier prostate cancer patients have larger tumors. The study of 3,327 patients revealed a direct correlation between BMI and tumor volume, suggesting that obesity may contribute to the aggressive nature of the disease.
A new ultrasensitive PSA test using nanoparticle technology can detect low levels of PSA in the blood that indicate cancer recurrence. The test may provide early and more accurate answers, allowing doctors to act at the earliest and most sensitive time for patients' long-term survival.
Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center present several studies at the 2010 American Urological Meeting, including a potential breakthrough in using 5-alpha reductase inhibitors to improve PSA test accuracy for prostate cancer diagnosis. Additionally, they present results on robotic surgery ...
Radiofrequency ablation proved as effective as surgical removal of tumors in curbing cancer recurrence rates for up to five years after treatment. The minimally invasive procedure showed superior preservation of kidney tissue, leading to improved quality of life and length of life for patients.
Researchers found men with ED had a 54% greater likelihood of high-risk CACS compared to those without ED. The study suggests ED is an independent risk factor for future cardiovascular disease.
Men who choose radiotherapy over surgery for prostate cancer have a 17% improvement in overall survival rate, with patients refusing treatment having a 51% 10-year survival rate. This study highlights the importance of considering treatment options when diagnosed with prostate cancer.
PSD502 demonstrates significant time to ejaculation and ejaculatory control improvements, with a 5.5-fold increase in IELT, compared to placebo. Men treated with PSD502 experience reduced premature ejaculation symptoms and increased satisfaction.
The REDUCE trial found dutasteride to be effective in reducing the chance of a positive biopsy by 23% and preventing disease progression. However, more detailed analyses are needed to monitor long-term effects on cardiovascular health and selectively identify aggressive disease.
A study published in the Journal of Urology found that girls with vesicoureteral reflux are at higher risk of new renal damage. Boys also showed signs of renal damage, although at lower rates. The study suggests that preventing febrile urinary tract infections is crucial for kidney health.
A recent study by S. Eggener et al. discusses the significance and impact of focal therapy for low-risk prostate cancer patients, highlighting its potential as an alternative to whole-gland treatment. The study reviews patient selection criteria, diagnostic imaging, biopsy schemes, and treatment modalities available for focal therapy.
Two surgical techniques for female stress incontinence were found to be equivalent in efficacy but differed in side effects. The retropubic procedure had a higher rate of urinary dysfunction requiring surgery compared to the transobturator procedure. These findings will help guide care for women undergoing stress-incontinence surgery.
Researchers at Thomas Jefferson University have identified a protein, IGF-IR, that regulates motility and invasion of bladder cancer cells. This finding offers a novel molecular target for treating patients with aggressive bladder cancer and may also serve as a tumor biomarker for diagnosis.
Research found that patients who discontinued OAB medication were more bothered by symptoms and had a medical diagnosis for conditions like incontinence. Smoking and certain health issues also increased the likelihood of stopping medication.
The EAU Congress ended its 25th anniversary meeting in Barcelona with awards for outstanding research in urology. Despite volcanic eruptions disrupting travel plans, the congress proceeded and recognized excellence in cancer and non-cancer research.
Researchers have evaluated a blood test that identifies patients with low-grade, low-stage prostate cancer who are at risk of needing treatment. The study found that a biomarker called Prostate Health Index was significant in predicting unfavorable biopsy conversion.
A blood test and DNA analysis accurately predict which men with low-grade prostate cancers may need treatment, say Johns Hopkins scientists. The prostate health index and DNA content in biopsy tissue can detect the progression of small prostate cancers.
A Phase 2 study demonstrated that BOTOX provides a clinically meaningful benefit for idiopathic OAB patients with urinary urgency incontinence. The study found that doses of 100U-150U provided the optimal balance between efficacy and safety, with significant reductions in symptoms and increases in PVR at higher doses.
The study demonstrates a potential new treatment paradigm in oncology with improved overall survival rates for metastatic castration-resistant prostate cancer patients. The treatment, Sipuleucel-T, was shown to have well-balanced prognostic factors and mild adverse events.
The European Association of Urology Congress highlights advances in renal cell carcinoma management, including immunotherapy, targeted therapies, and angiogenesis blockers. New treatments like bevacizumab, sunitinib, sorafenib, temsirolimus, and everolimus have shown promise in stabilizing metastatic kidney cancer for a certain period.
The EORTC 30904 study found that conservative surgery is not inferior to radical renal surgery or nephrectomy, with a slightly higher complication rate. Overall survival rates were shorter on the conservative arm for all randomized patients, but not different for RCC or clinically/pathologically eligible patients.
The European Association of Urology does not recommend mass screening for prostate cancer in Europe, citing the risk of overdiagnosis and overtreatment. Men should be properly informed by their physician about the pros and cons of screening, such as a PSA test.
The European Association of Urology (EAU) has launched new and updated clinical guidelines for urological conditions, including muscle-invasive and metastatic bladder cancer and prostate cancer. The guidelines provide evidence-based recommendations on diagnosis, staging, treatment options, and follow-up care.
Several urological experts were awarded prestigious medals and prizes for their groundbreaking work, including Prof. Frans Debruyne and Prof. James Catto. The awards recognized their efforts to advance urology through innovative technologies and research.
UK researchers found that many urologists fail to diagnose and treat Chlamydia in young men, despite clear guidelines. In a survey of five teaching hospitals, only 7% of cases were tested for Chlamydia, and most received inadequate treatment.
Researchers at Nationwide Children's Hospital developed a mouse model of vesicoureteral reflux, a condition that can lead to chronic kidney disease. The study found that these models lacked the protein fibroblast growth factor receptor 2 (Fgfr2), which is involved in tissue and organ development.
Researchers have designed an experimental drug called OSU-CG12 that kills cancer cells by choking off their energy supply. The agent targets a survival mechanism used by many types of cancer, and its efficacy is 10 times better than a comparable drug, resveratrol.
Researchers at Emory University have successfully developed a clinical test for XMRV, a retrovirus linked to prostate cancer, using neutralizing antibody assay technology. The test has been confirmed by two independent labs and technologies, providing confidence in its accuracy.
A study published in the World Journal of Gastroenterology found that colonoscopy in Hong Kong Chinese children has a high safety yield and can effectively diagnose inflammatory bowel disease. The procedure also provided therapeutic value by successfully removing colonic polyps, with no complications reported.